Envestnet Asset Management Inc. Buys 1,962 Shares of Ceridian HCM Holding Inc. (NYSE:CDAY)

Envestnet Asset Management Inc. grew its holdings in shares of Ceridian HCM Holding Inc. (NYSE:CDAYGet Rating) by 9.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,230 shares of the company’s stock after acquiring an additional 1,962 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Ceridian HCM were worth $1,490,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Lazard Asset Management LLC purchased a new position in shares of Ceridian HCM in the third quarter worth $25,000. Advisors Asset Management Inc. purchased a new position in Ceridian HCM during the 1st quarter valued at $41,000. Parallel Advisors LLC increased its position in Ceridian HCM by 55.6% during the 4th quarter. Parallel Advisors LLC now owns 896 shares of the company’s stock valued at $57,000 after purchasing an additional 320 shares during the period. Signaturefd LLC increased its position in Ceridian HCM by 51.3% during the 3rd quarter. Signaturefd LLC now owns 1,657 shares of the company’s stock valued at $93,000 after purchasing an additional 562 shares during the period. Finally, US Bancorp DE increased its position in Ceridian HCM by 133.5% during the 1st quarter. US Bancorp DE now owns 1,880 shares of the company’s stock valued at $128,000 after purchasing an additional 1,075 shares during the period.

Ceridian HCM Trading Up 3.0 %

CDAY stock opened at $63.40 on Tuesday. Ceridian HCM Holding Inc. has a 1-year low of $43.23 and a 1-year high of $79.66. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $9.71 billion, a price-to-earnings ratio of -264.17 and a beta of 1.44. The business has a 50 day simple moving average of $65.70 and a two-hundred day simple moving average of $67.40.

Insiders Place Their Bets

In other news, EVP William Everett Mcdonald sold 709 shares of the stock in a transaction that occurred on Tuesday, May 9th. The stock was sold at an average price of $57.82, for a total transaction of $40,994.38. Following the completion of the transaction, the executive vice president now directly owns 53,626 shares in the company, valued at approximately $3,100,655.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP William Everett Mcdonald sold 709 shares of the firm’s stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $57.82, for a total value of $40,994.38. Following the completion of the sale, the executive vice president now directly owns 53,626 shares in the company, valued at $3,100,655.32. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Leagh Erin Turner sold 6,000 shares of the firm’s stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $74.82, for a total value of $448,920.00. Following the completion of the sale, the chief executive officer now owns 245,201 shares of the company’s stock, valued at $18,345,938.82. The disclosure for this sale can be found here. Insiders sold 36,896 shares of company stock worth $2,616,959 in the last three months. 4.50% of the stock is owned by company insiders.

Analyst Ratings Changes

CDAY has been the topic of a number of research analyst reports. BMO Capital Markets boosted their price objective on shares of Ceridian HCM from $73.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 9th. Mizuho upped their price target on shares of Ceridian HCM from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, February 9th. Credit Suisse Group dropped their price target on shares of Ceridian HCM from $105.00 to $83.00 in a research note on Thursday, May 4th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Ceridian HCM from $82.00 to $90.00 in a research note on Thursday, February 9th. Finally, Cowen upped their price target on shares of Ceridian HCM from $77.00 to $87.00 and gave the company an “outperform” rating in a research report on Thursday, February 9th. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $77.27.

About Ceridian HCM

(Get Rating)

Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.

Further Reading

Institutional Ownership by Quarter for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.